You are here

Pfizer’s Competitive Grants Program

Due to the ongoing Coronavirus (COVID-19) pandemic, we ask for your patience regarding possible delays in the processing of new grant requests. The Global Medical Grants (GMG) team is currently providing grantees of current/ongoing studies and initiatives with information to ensure the health and safety of all involved in Pfizer-supported activities.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an external review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the research/quality improvement program.

Open RFPs

2020 Breast Cancer Competitive Research Grant Program for Africa, the Middle East, Asia and Latin America Regions

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research

Transthyretin Cardiac Amyloidosis Fellowship

2020 Transthyretin Amyloid Polyneuropathy (ATTR-PN) Research Competitive Grant Program for Junior Investigators

2020 Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research Competitive Grant Program for Junior Investigators

The 2020 Acromegaly/Growth Hormone Excess Research

The 2020 Growth Hormone Research Competitive Grant Program

Gene & Anti-TFPI Therapies in Hemophilia

Hemophilia Research in Africa-Middle East, Asia Pacific, China and Latin America

Inflammation ASPIRE 2020 Ulcerative colitis International Developed Markets

Inflammation ASPIRE 2020 Rheumatology International Developed Markets